Kathryn J Ray

Summary

Publications

  1. pmc A rationale for continuing mass antibiotic distributions for trachoma
    Kathryn J Ray
    Francis I, Proctor Foundation, University of California, San Francisco, CA, USA
    BMC Infect Dis 7:91. 2007
  2. pmc Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California, San Francisco, CA, USA
    Ophthalmic Epidemiol 20:155-8. 2013
  3. pmc Visual outcomes in treated bacterial keratitis: four years of prospective follow-up
    Scott M McClintic
    Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States
    Invest Ophthalmol Vis Sci 55:2935-40. 2014
  4. pmc Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
  5. pmc Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis
    Kathryn J Ray
    Francis I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    JAMA Ophthalmol 131:310-3. 2013
  6. doi request reprint Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial
    Jenafir I House
    FI Proctor Foundation, University of California, San Francisco, USA
    Lancet 373:1111-8. 2009
  7. doi request reprint Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial
    Travis C Porco
    F I Proctor Foundation, and Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA
    JAMA 302:962-8. 2009
  8. pmc When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries
    Kathryn J Ray
    F I Proctor Foundation, University of California, San Francisco, California, United States of America
    PLoS Negl Trop Dis 3:e458. 2009
  9. ncbi request reprint Early addition of topical corticosteroids in the treatment of bacterial keratitis
    Kathryn J Ray
    F I Proctor Foundation, University of California, San Francisco2Department of Epidemiology and Biostatistics, University of California, San Francisco
    JAMA Ophthalmol 132:737-41. 2014
  10. doi request reprint Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California San Francisco, 513 Parnassus Avenue, Room S309, San Francisco, CA 94117, USA
    Invest Ophthalmol Vis Sci 54:1522-6. 2013

Collaborators

Detail Information

Publications19

  1. pmc A rationale for continuing mass antibiotic distributions for trachoma
    Kathryn J Ray
    Francis I, Proctor Foundation, University of California, San Francisco, CA, USA
    BMC Infect Dis 7:91. 2007
    ..Here we use mathematical models to demonstrate that repeated antibiotic distributions can eliminate infection in a reasonable time period...
  2. pmc Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California, San Francisco, CA, USA
    Ophthalmic Epidemiol 20:155-8. 2013
    ..To describe temporal trends in Pseudomonas aeruginosa resistance to moxifloxacin in keratitis isolates from South India...
  3. pmc Visual outcomes in treated bacterial keratitis: four years of prospective follow-up
    Scott M McClintic
    Department of Ophthalmology, University of California, San Francisco, San Francisco, California, United States
    Invest Ophthalmol Vis Sci 55:2935-40. 2014
    ..We described the change in visual acuity experienced by eyes successfully treated for bacterial keratitis...
  4. pmc Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
    ....
  5. pmc Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis
    Kathryn J Ray
    Francis I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    JAMA Ophthalmol 131:310-3. 2013
    ..To analyze the relationship between fluoroquinolone use at presentation and minimum inhibitory concentration in bacterial keratitis...
  6. doi request reprint Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial
    Jenafir I House
    FI Proctor Foundation, University of California, San Francisco, USA
    Lancet 373:1111-8. 2009
    ..We assessed indirect protection against trachoma with mass azithromycin distributions...
  7. doi request reprint Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial
    Travis C Porco
    F I Proctor Foundation, and Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143, USA
    JAMA 302:962-8. 2009
    ..Antibiotics are provided to target the ocular strains of chlamydia that cause trachoma, but may also be efficacious against respiratory disease, diarrhea, and malaria--frequent causes of childhood mortality in trachoma-endemic areas...
  8. pmc When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries
    Kathryn J Ray
    F I Proctor Foundation, University of California, San Francisco, California, United States of America
    PLoS Negl Trop Dis 3:e458. 2009
    ..While this can be tested empirically, results will not be available for years. Here we use a mathematical model to predict results with different graduation strategies in three African countries...
  9. ncbi request reprint Early addition of topical corticosteroids in the treatment of bacterial keratitis
    Kathryn J Ray
    F I Proctor Foundation, University of California, San Francisco2Department of Epidemiology and Biostatistics, University of California, San Francisco
    JAMA Ophthalmol 132:737-41. 2014
    ..CONCLUSIONS AND RELEVANCE There may be a benefit with adjunctive topical corticosteroids if application occurs earlier in the course of bacterial corneal ulcers. ..
  10. doi request reprint Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California San Francisco, 513 Parnassus Avenue, Room S309, San Francisco, CA 94117, USA
    Invest Ophthalmol Vis Sci 54:1522-6. 2013
    ..In this report, we analyze the role of moxifloxacin susceptibility in the relationship between causative organisms and clinical outcome in bacteria keratitis...
  11. doi request reprint Complete elimination is a difficult goal for trachoma programs in severely affected communities
    Deborah A Gill
    F I Proctor Foundation, San Francisco, USA
    Clin Infect Dis 46:564-6. 2008
    ..Theoretically, a loftier goal of elimination is feasible. Here, we demonstrate that, although local elimination of infection in the most severely affected communities is difficult, it is possible with biannual antibiotic distributions...
  12. pmc Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I
    Catherine Q Sun
    Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, USA
    Invest Ophthalmol Vis Sci 54:4167-73. 2013
    ..To perform a Bayesian analysis of the Mycotic Ulcer Treatment Trial I (MUTT I) using expert opinion as a prior belief...
  13. doi request reprint The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial
    Fengchen Liu
    F I Proctor Foundation, University of California, San Francisco, CA, USA
    Epidemics 6:10-7. 2014
    ..We found no evidence of decreased efficacy during the course of the trial. We estimated an 89% chance of elimination after 10 years of annual treatment with 95% coverage. ..
  14. pmc The epidemiological dynamics of infectious trachoma may facilitate elimination
    Thomas M Lietman
    F I Proctor Foundation, University of California, San Francisco, CA, 94143 0412, USA
    Epidemics 3:119-24. 2011
    ..Here, we use mathematical models to assess whether more ambitious goals such as local elimination or even global eradication are possible...
  15. pmc Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity
    Fengchen Liu
    F I Proctor Foundation, University of California, San Francisco, California, USA
    PLoS Negl Trop Dis 7:e2303. 2013
    ..This is encouraging, as it allows the possibility that repeated mass antibiotic distributions may eliminate infection from even the most severely affected areas. ..
  16. doi request reprint Estimating community prevalence of ocular Chlamydia trachomatis infection using pooled polymerase chain reaction testing
    Kathryn J Ray
    F I Proctor Foundation, University of California, San Francisco, CA, USA
    Ophthalmic Epidemiol 21:86-91. 2014
    ..Here we demonstrate simulations of pooled PCR results may estimate infection prevalence of an entire community yielding substantial cost savings if pool size is chosen correctly...
  17. pmc Effect of the one-child policy on influenza transmission in China: a stochastic transmission model
    Fengchen Liu
    F I Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America Center for Infectious Diseases and Emergency Readiness, School of Public Health, University of California, Berkeley, California, United States of America
    PLoS ONE 9:e84961. 2014
    ..Moreover, changes in household structure may affect influenza transmission. Is it possible that the pronounced demographic changes that have occurred in China have affected influenza transmission?..
  18. pmc Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study
    Durga S Borkar
    F I Proctor Foundation, University of California, San Francisco, San Francisco, California, USA
    Ophthalmology 120:451-6. 2013
    ..To provide a population-based estimate of the incidence of herpes zoster ophthalmicus (HZO) with comparisons across racial, sex, and age groups, as well as to estimate the frequency of postherpetic neuralgia (PHN)...
  19. pmc Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial
    Craig W See
    FI Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    Ophthalmic Epidemiol 19:407-13. 2012
    ..To elicit expert opinion on the use of adjunctive corticosteroid therapy in bacterial corneal ulcers. To perform a Bayesian analysis of the Steroids for Corneal Ulcers Trial (SCUT), using expert opinion as a prior probability...